N. Sirisophana

发表

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais.

J. Mascola, D. Birx, S. Nitayaphan, 2000 .

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.

J. Mascola, D. Birx, S. Nitayaphan, 2000, Vaccine.